Antioxidant micronutrients for lung disease in cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Shamseer, Larissa ^a   Adams, D ^b   Vohra, S ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; SELENIUM; TRACE ELEMENT;

CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFECT; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; MONOTHERAPY; OXIDATIVE STRESS; QUALITY OF LIFE; REVIEW; VITAMIN SUPPLEMENTATION;

EID: 44949254129     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007020     Document Type: Review

References (21)

1. Back 2004 Back EI, Frindt C, Nohr D, Frank J, Ziebach R, Stern M, et al.Antioxidant deficiency in cystic fibrosis: when is the right time to take action?. American Journal of Clinical Nutrition 2004;80(2):374-84.
2. Begg 1994 Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4): 1088-101.
3. CCFF 2002 Canadian Cystic Fibrosis Foundation. Report of the Canadian Patient Data Registry. Canadian Patient Data Registry [Toronto, Ontario] 2002.
4. CFF 2005 Cystic Fibrosis Foundation. Patient Registry 2005. Annual Data Report [Bethesda, Maryland] 2005.
5. Ciabattoni 2000 Ciabattoni G, Davi G, Collura M, Iapichino L, Pardo F, Ganci A, et al.In vivo lipid peroxidation and platelet activation in cystic fibrosis. American Journal of Respiratory & Critical Care Medicine 2000;162(4 part 1):1195-201.
6. Egger 1997 Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
7. Goss 2004 Goss CH, Rosenfeld M. Update on cystic fibrosis epidemiology. Current Opinion in Pulmonary Medicine 2004;10(6): 510-4.
8. Hamutcu 2001 Hamutcu R, Woo MS. Advanced cystic fibrosis lung disease in children. Current Opinion in Pulmonary Medicine 2001;7(6):448-53.
9. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
10. Jüni 2001 Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
11. Light 1994 Light R, Pillemer D. Summing Up: The Science of Reviewing Research. Cambridge: Harvard University Press, 1984.
12. Lyczak 2002 Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clinical Microbiology Reviews 2002;15(2):194-222.
13. Mayne 2003 Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. The Journal of Nutrition 2003;133(Suppl 3):933S-40S.
14. Montuschi 1998 Montuschi P, Ciabattoni G, Paredi P, Pantelidis P, du Bois RM, Kharitonov SA, et al.8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. American Journal of Respiratory and Critical Care Medicine 1998;158(5 Pt 1):1524-7.
15. O'Neil 2007 O'Neil C, Chang AB, Shevill E. Vitamin A supplementation for cystic fibrosis (Cochrane Review). Cochrane Database of Systematic Reviews 2007, Issue 4.Art. No.: CD006751. DOI:10.1002/14651858. CD006751.pub2.
16. Pellegrino 2005 Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al.Interpretative strategies for lung function tests. Series "ATS/ERS Task Force: Standardisation of lung function testing". Number 5 in this series. European Respiratory Journal 2005;26(5):948-68.
17. Repine 1997 Repine JE, Bast A, Lankhorst I, The Oxidative Stress Study Group. Oxidative Stress in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 1997;156(2 Pt 1):341-57.
18. Schunemann 1997 Schunemann HJ, Muti P, Freudenheim JL, Armstrong D, Browne R, Klocke RA, et al.Oxidative stress and lung function. American Journal of Epidemiology 1997;146(11):939-48.
19. Winklhofer-Roob 1994 Winklhofer-Roob BM. Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance. Acta Paediatrica 1994;83(395):49-57.
20. Wood 2001 Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Collins CD, Garg ML. Oxidative Stress in Cystic Fibrosis: Dietary and Metabolic Factors. Journal of the American College of Nutrition 2001; Vol. 20, issue 2:157-65.
21. Wood 2003 Wood LG, Fitzgerald DA, Lee AK, Garg ML. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. The American Journal of Clinical Nutrition 2003;77(1):150-9.